Breadcrumb

Spotlight

Recent awards and honors bestowed upon the CBL

Molecular Discovery Seminar Series

Thursdays at 10:00 am

Job Vacancies

We have no open positions in our group at this time, please check back later.

To see all available positions at CCR, take a look at our Careers page. You can also subscribe to receive CCR's latest job and training opportunities in your inbox.

News

CBL Ushers in 2024 with an NCI Director's Innovation Award

Image
Shaifaly Parmar
Dr. Shaifaly Parmar

Congratulations to Dr. Shaifaly Parmar, a postdoctoral Fellow in the Schneekloth group for securing a 2024 NCI Director's Innovation Award. Her proposal entitled, “Severing fusion oncogene using small molecules” was evaluated based on degree of innovation and potential for high-impact breakthroughs; and follows the NIH 9-point scoring system used for grant applications.  This award provides funding to pursue this project.

Twin Win for CBL Alum Dr. Yuji Yamada

Image
Dr. Yuji Yamada
Dr. Yuji Yamada

Congratulations go out to CBL Schneider Group Alum, Dr. Yuji Yamada, currently a Lecturer at the Tokyo University of Pharmacy and Life Sciences, on his presentation entitled, “Application of cell adhesive peptides to biomaterials”.  This presentation earned Dr. Yamada a 2023 Annual Award by the The Pharamceutical Society of Japan and a 2023 Young Investigator Award by The Japanese Peptide Society.

Dr. Fa Liu: A meteoric rise from Postdoc to CSO

Image
Dr. Fa Liu
Dr. Fa Liu

Dr. Fa Liu joined the CBL as a Visiting Fellow in the Burke Group in 2004 (known as the Laboratory of Medicinal Chemistry at the time) after obtaining his B.S (Nankai University) and Ph.D. (Shanghai Institute of Organic Chemistry) in chemistry.  In 2009 he joined Eli Lilly, where he led multiple peptide lead optimization efforts and established well-recognized modern insulin chemistries. He then moved over to Calibrium, Inc. where he was instrumental in building the company’s pipeline until its acquisition by Novo Nordisk. He served as the Head of Chemistry at Novo Nordisk, and led its peptide and protein therapeutics discovery. In 2020 he co-founded Focus-X Therapeutics, where he served as CEO.  In 2023 Focus-X was purchased by Full-Life Therapeutics, where Dr, Liu now serves as its Chief Scientific Officer. In this capacity he discovered five compounds that progressed into human studies, and contributed to other compounds currently in clinical trials in addition to the discovery the FDA approved drug Lyumjev® (insulin lispro-aabc).

Dr. Melissa Lucero wins 2024 Nobel Laureate Signature Award for Graduate Education in Chemistry

Image
Drs. Jeff Chan and Melissa Lucero
Dr. Jeff Chan (left) and Dr. Melissa Lucero (right)

Dr. Melissa Lucero, a Postdoctoral Fellow in the Schnermann group, has won a 2024 ACS Nationl Award - the Nobel Laureate Signature Award for Graduate Education in Chemistry. This national award was established in 1978 by Avantor and serves to encourage the advancement of chemistry in all its branches, support research endeavors, and promote the careers of chemists. Dr. Lucero was recognized for her work with Dr. Jefferson Chan (University of Illinois Urbana-Champaign) developing non-toxic small-molecule probes for visualization.  National award recipients will be honored at the award ceremony Tuesday, March 19, 2024, in conjunction with ACS Spring 2024 in New Orleans.

Best Presentation Award - RetroIntegration2023 Conference

Image
Zhao
Dr. Xue Zhi Zhao

The CBL congratulates its own Dr. Xue Zhi Zhao, a Senior Associate Scientist in the Burke group, for winning a Best Presentation award for his poster entitled  "Structure-guided Optimization of HIV Integrase Strand Transfer Inhibitors" at RetroIntegration2023, the 7th International Conference on Retroviral Integration, hosted by the University of Colorado Anschutz Medical Campus and held in Boulder, CO this summer.

Revealing HIV drug-resistance mechanisms through protein structures

Image
(L-R) NCI scientists Steven Smith, Steve Hughes, Terry Burke and Xuezhi Zhao
(L-R) NCI scientists Steven Smith, Steve Hughes, Terry Burke and Xue Zhi Zhao

Molecular mechanisms by which HIV becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for treating HIV have been discovered through a collaboration between the NCI and the Salk Institute.  This new study, published in Science Advances on July 21, 2023, reveals how changes to the 3D structures of integrase, an HIV protein, can lead to Dolutegravir resistance and how other compounds may be able to overcome this resistance.  Read more on MedicalXpress and ScienceDaily.

CBL Fellow wins 2023 Dr. Elizabeth A. Schram Award

Image
Sarkar

CBL congratulates its own Dr. Srijani Sarkar, a Post-doctoral Fellow in the Schneider Lab for winning the Dr. Elizabeth A. Schram award a the 28th American Peptide Symposium held in Scottsdale, AZ on June 24-29, 2023.  Dr. Sarkar's poster entitled "Enhancement in the Mechanical Rigidity of Peptide Hydrogels by a Library of Dialdehyde Crosslinkers" earned her this award, which is given for the best presentation in the Young Investigator Poster Competition.

CBL Fellows Secure FARE 2024 Travel Awards

Image
Shaifaly and Supuni

Dr. Shaifaly Parmar (left) of the Schneekloth Group and Dr. Supuni Thalalla Gamage (right) of the Meier Group, earned FARE Travel Awards for 2024. The Fellows Award for Research Excellence (FARE), began in 1995 to recognize the outstanding scientific research performed by intramural postdoctoral fellows. The FARE award is a $1500 travel grant used to cover costs related to attending a scientific meeting in the US during the upcoming fiscal year.

2023 Cathay Award

Image
Schneider

Kudos to Dr. Joel P. Schneider, Deputy Director for the Center for Cancer Research and Chemical Biology Laboratory Laboratory Chief who received the 2023 Cathay Award from the Chinese Peptide Society in recognition of his outstanding contributions to peptide science.

Dr. Pankaj Mahajan wins 2023 Intramural AIDS Research Fellowship Award

Image
Mahajan

Dr. Pankaj Mahajan, a post-doctoral Fellow in the Burke Group has been selected to receive an Intramural AIDS Research Fellowship in support of his research entitled, "N-Substituted Bicyclic Carbamoyl Pyridones (BiCAPs) as New Integrase Strand Transfer Inhibitors (INSTIs) Against the Drug-resistant Mutants of HIV-1 IN".  Having demonstrated outstanding scientific potential through both a well thought out career development plan and a creative and thoughtful research plan, the Office of AIDS Research, the Office of Intramural Research (OIR), and the Office of Intramural Training & Education (OITE) have selected Dr. Mahajan for this award which provides funds to cover his stipend and health insurance.  A major mission of the NIH Intramural Research Program (IRP) and the Office of AIDS  Research (OAR), is to train the next generation of researchers to continue the battle to halt the AIDS pandemic.

Dr. Xue Zhi Zhao Wins 2023 Travel Award

Image
Zhao

Congratulations go to Dr. Xue Zhi Zhao, an Associate Scientist in the Burke Group, for being selected as a winner at the 2023 CCR and DCEG Staff Scientist and Staff Clinician Retreat.  This theme of this year’s retreat was “Redefining What’s Possible: Development of novel cancer therapies”.  Dr. Zhao's poster entitled, "Development of multidentate tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors” earned him a financial travel award for use to attend and present this work at a scientific meeting this year.

Congratulations to 2023 NCI Director's Award recipient, Dr. Joel Schneider

Image
Schneider

CBL Lab Chief, Dr. Joel P. Schneider was awarded a Department of Defense Reconstructive Transplant Research Program Award for his proposal, "Localized & Inflammation-Responsive Immunotherapy of VCA Rejection".  The Director's Awards recognize important achievements made by NCI staff in support of the NCI mission. 

Dr. John "Jay" Schneekloth, 2023 CCR FLEX Awardee

Image
Schneekloth

In collaboration with Drs. Susan Lea and Hans Elmlund of the Center for Structural Biology, the CBL's own Dr. Jay Schneekloth was awarded a 2023 FLEX award for their proposal “Understanding RNA-Ligand Complexes with Cryo-Electron Microscopy and Chemistry”.  The CCR FLEX Program is a means for CCR PIs to fund high-risk, high-impact projects that may be difficult to perform within their base allocation. The program facilitates technology development, the ability of PIs to embark on new directions, and creation of multi-PI collaborations. Since 2015, there have been 68 FLEX Awards that have resulted in over 100 publications, many in top-tier journals, as well as 24 new clinical trials and numerous commercial partnerships. 

Resources

4j12 molecule

Seminars & Events

CBL sponsors several seminars and events targeted to various research and professional interests throughout the year. Click on one of the links below to see the schedule and to learn more.

Fellows at retreat

Meet Our People

The Chemical Biology Laboratory boasts a wide variety of expertise stemming from outstanding fellows from diverse backgrounds who join the Lab for a Postbaccalaureate or Postdoctoral Fellowship. 

Alumni

Kavita Belligund
Dr. Kavita Belligund
2021-2023
NIH Visiting Fellow
sierra marker
Dr. Sierra Marker
2020-2023
NIH CRTA Fellow
Diamond Gallimore
Diamond Gallimore
2021-2023
NIH Postbac CRTA Fellow
Nya Evans
Nya Evans
2022-2023
NIH Postbac CRTA Fellow
Seth Allen
Seth Allen
2012-2023
NIH Postbac CRTA Fellow
Seshadri
Srinath Vijay Seshadri
2021-2023
NIH Visiting Fellow
Syed Usama
Dr, Syed Usama
2019-2023
NIH Visiting Fellow
Brown
Zachary Brown
2021-2023
NIH Postbac CRTA Fellow
Gillmann
Kara Gillmann
2021-2023
NIH Postbac CRTA Fellow
Marglous
Samantha Marglous
2021-2023
NIH Postbac CRTA Fellow
Tripu
Deepika Tripu
2022-2023
NIH Postbac CRTA Fellow
Donghao Li
Dr. Donghao Li
2022-2023
NIH Visiting Fellow
Wang
Dr. Xiaoyi (Eileen) Wang
2019-2023
NIH Visiting Fellow

This is just a small sample of our most recent alumni. Over the years, our lab has trained a cadre of outstanding postdoctoral, doctoral and postbaccalaureate fellows. Many have gone on to hold leading positions in the scientific community.

View All Alumni